Corient Private Wealth Portfolio holdings
Corient Private Wealth is the U.S. wealth management business that grew out of Canadian asset manager CI Financial's push into American wealth advisers. It was called CI Private Wealth until 2023, when it took the name Corient, a play on the words "client" and "oriented." Its advisers typically manage client portfolios by hiring and replacing outside investment managers and choosing individual securities, guided by an investment committee. Clients include individuals, among them high-net-worth individuals, as well as trusts, estates and charitable organizations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$313M |
| 2 |
RTX Corp
RTX
|
+$247M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 4 |
Quanta Services
PWR
|
+$126M |
| 5 |
Marvell Technology
MRVL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$449M |
| 2 |
NVIDIA
NVDA
|
+$392M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$375M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$331M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.68% |
| 2 | Technology | 19.67% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 7.58% |
| 5 | Healthcare | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$380M
| $202K | ﹤0.01% |
+1,290
| New | +$195K |
2026 Q2
0 quarters
|
|
2802
DTF Tax-Free Income 2028 Term Fund
DTF
$80.3M
| $202K | ﹤0.01% |
17,518
-23
| -0.1% | -$263 |
2023 Q1
13 quarters
|
|
2803
Albany International
AIN
$1.9B
| $202K | ﹤0.01% |
+2,714
| New | +$170K |
2026 Q2
0 quarters
|
|
2804
Alpha Tau Medical
DRTS
$1.21B
| $202K | ﹤0.01% |
+16,036
| New | +$146K |
2026 Q2
0 quarters
|
|
2805
Chatham Lodging
CLDT
$687M
| $201K | ﹤0.01% |
15,182
+4,574
| +43% | +$47.3K |
2026 Q1
1 quarter
|
|
2806
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
$1.38B
| $201K | ﹤0.01% |
+9,554
| New | +$182K |
2026 Q2
0 quarters
|
|
2807
iShares Broad USD High Yield Corporate Bond ETF
USHY
$26B
| $201K | ﹤0.01% |
+5,425
| New | +$201K |
2026 Q2
0 quarters
|
|
2808
Sprott Physical Silver Trust
PSLV
$10.1B
| $200K | ﹤0.01% |
10,601
+811
| +8% | +$19.1K |
2025 Q4
2 quarters
|
|
2809
Qiagen
QGEN
$10.4B
| $200K | ﹤0.01% |
5,114
-2,969
| -37% | -$110K |
2025 Q3
3 quarters
|
|
2810
Bioventus
BVS
$910M
| $200K | ﹤0.01% |
21,152
-623
| -3% | -$5.95K |
2025 Q2
4 quarters
|
|
2811
DoubleLine Yield Opportunities Fund
DLY
$642M
| $199K | ﹤0.01% |
14,151
-4,690
| -25% | -$65.8K |
2025 Q2
4 quarters
|
|
2812
Coeur Mining
CDE
$13.5B
| $198K | ﹤0.01% |
12,132
-150,083
| -93% | -$2.74M |
2024 Q2
8 quarters
|
|
2813
BlackRock MuniHoldings Fund
MHD
$1.9B
| $198K | ﹤0.01% |
+16,613
| New | +$194K |
2026 Q2
0 quarters
|
|
2814
Arq
ARQ
$77.3M
| $198K | ﹤0.01% |
77,525
+25
| +0% | +$62 |
2026 Q1
1 quarter
|
|
|
AXIA.PRC
2815
DELISTED
AXIA Energia American Depositary Shares Preferred Class C
AXIA.PRC
| $197K | ﹤0.01% |
18,651
-135
| -0.7% | -$1.48K |
2025 Q4
2 quarters
|
|
2816
Nuveen California Quality Municipal Income Fund
NAC
$1.62B
| $195K | ﹤0.01% |
16,090
| – | – |
2024 Q2
8 quarters
|
|
2817
Pitney Bowes
PBI
$2.21B
| $194K | ﹤0.01% |
11,077
-7,479
| -40% | -$114K |
2025 Q2
4 quarters
|
|
2818
Orion
OEC
$317M
| $194K | ﹤0.01% |
29,183
+17,683
| +154% | +$127K |
2026 Q1
1 quarter
|
|
2819
Apollo Commercial Real Estate
ARI
$300M
| $193K | ﹤0.01% |
+18,048
| New | +$197K |
2026 Q2
0 quarters
|
|
2820
QuantumScape Corp
QS
$2.51B
| $192K | ﹤0.01% |
25,411
+7,671
| +43% | +$57.5K |
2025 Q1
5 quarters
|
|
2821
Ellington Financial
EFC
$1.47B
| $192K | ﹤0.01% |
14,082
+2,743
| +24% | +$36.3K |
2024 Q4
6 quarters
|
|
2822
Sibanye-Stillwater
SBSW
$6.08B
| $192K | ﹤0.01% |
22,572
-2,849
| -11% | -$33.2K |
2024 Q3
7 quarters
|
|
2823
Arcos Dorados Holdings
ARCO
$1.42B
| $190K | ﹤0.01% |
23,619
-192
| -0.8% | -$1.66K |
2026 Q1
1 quarter
|
|
2824
Recursion Pharmaceuticals
RXRX
$2.41B
| $189K | ﹤0.01% |
+51,561
| New | +$172K |
2026 Q2
0 quarters
|
|
2825
Gladstone Commercial Corp
GOOD
$553M
| $188K | ﹤0.01% |
+15,255
| New | +$190K |
2026 Q2
0 quarters
|
|
Similar funds
Corient Private Wealth's Q2 2026 Portfolio in Review
As of Q2 2026, Corient Private Wealth held 3,273 positions worth $72.2B, up 3.4% from $69.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Corient Private Wealth withdrew a net $6.91B in Q2 2026, closing 231 positions and reducing 1,294 holdings. Its most notable exit was Masimo, an estimated $57.2M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 37% a quarter earlier, followed by Technology and Financials.
Against the trend, Corient Private Wealth opened a new position in Powerlaw Corp worth $56.7M.
- Corient Private Wealth's largest Q2 2026 buy was Powerlaw Corp: 3,862,217 shares worth $56.7M.
- Corient Private Wealth added most to Invesco QQQ Trust in Q2 2026, an estimated $313M increase.
- Corient Private Wealth's biggest Q2 2026 reduction was Schwab International Equity ETF, cutting an estimated $449M.
- Corient Private Wealth fully exited Masimo in Q2 2026, selling an estimated $57.2M.
- Corient Private Wealth's ten largest holdings make up 27% of its $72.2B portfolio in Q2 2026.
- Corient Private Wealth opened 439 new positions and closed 231 in Q2 2026.
- Corient Private Wealth's portfolio value rose 3.4% quarter-over-quarter to $72.2B.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.